Mantle Cell Lymphoma and Anti-MuSK-Positive Myasthenia gravis

Publisher： Karger

E-ISSN： 2296-5262|34|7|382-383

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.34, Iss.7, 2011-06, pp. : 382-383

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Incidence of acetylcholine receptor‐antibody‐positive myasthenia gravis in South Africa

By  

MUSCLE AND NERVE, Vol. 51, Iss. 4, 2015-04 ,pp. : 533-537

John Wiley & Sons Inc

Access to resources Recommend Favorite

Myasthenia gravis associated with ipilimumab and nivolumab in the treatment of small cell lung cancer

By  

MUSCLE AND NERVE, Vol. 52, Iss. 2, 2015-08 ,pp. : 307-308

John Wiley & Sons Inc

Access to resources Recommend Favorite

Differential regulation patterns of the anti‐CD20 antibodies obinutuzumab and rituximab in mantle cell lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 4, 2015-02 ,pp. : 606-610

John Wiley & Sons Inc

Access to resources Recommend Favorite

Myasthenia Gravis in the Elderly

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 24, Iss. 5, 1976-05 ,pp. : 228-231

John Wiley & Sons Inc

Access to resources Recommend Favorite

Myasthenia Gravis in Pregnancy

By  

NURSING FOR WOMENS HEALTH, Vol. 19, Iss. 3, 2015-06 ,pp. : 248-252

John Wiley & Sons Inc

Access to resources Recommend Favorite